NIMedical - Leading Developer and Manufacturer of Whole Body Bioimpedance Systems
Company Profile
NIMedical is a biotechnology company, the world’s leading developer and manufacturer of whole body bioimpedance systems, the Non Invasive Cardiac System (NICaS) and the Hemodynamic Navigator.
Our Vision:To provide noninvasive cardiac output measurement as a standard of care for hemodynamic management of cardiovascular patients. This will:
NIMedical is a biotechnology company, the world’s leading developer and manufacturer of whole body bioimpedance systems, the Non Invasive Cardiac System (NICaS) and the Hemodynamic Navigator.
Our Vision: To provide noninvasive cardiac output measurement as a standard of care for hemodynamic management of cardiovascular patients. This will:
Reduce length of stay in hospital
Significantly improve patients’ medical outcome
Keep patients out of hospital
Provide good medical practice
Our Technology- Non Invasive Monitoring: The only noninvasive technology to continuously measure peripheral blood flow, resistance and fluids. The measurement is done by placing two disposable sensors on the patient’s wrist and contralateral ankle. The display provides patient’s hemodynamic trends (including Stroke volume, Cardiac output, Total peripheral resistance, Cardiac power and Total body water) which enable clinicians to facilitate optimal treatment and quick monitored response.
The NICaS, is a state of the art, low cost and easy to use cardiac monitor that can significantly improve the management of cardiovascular patients. NICaS is designed to be used by clinicians in Hospitals, outpatient Facilities, and Home Healthcare programs. The Hemodynamic Navigator is a sophisticated graphic display that provides a simple and clear trend of patient’s hemodynamics. Our next generation product, currently under development, is designed as a Smartphone application to be used at home by the patient as a telemedicine device, transmitting physiological data to the physician for evaluation. This would be revolutionary in the management of cardiovascular patients resulting in significant reduction of hospitalizations and savings to the healthcare system.
Medical Devices
